Intravenous gammaglobulin (IVIG): a novel approach to improve transplant rates and outcomes in highly HLA-sensitized patients (Q36392146)

13 August 2017

1 reference

title

Intravenous gammaglobulin (IVIG): a novel approach to improve transplant rates and outcomes in highly HLA-sensitized patients (English)

1 reference

13 August 2017

Jordan SC

1

1 reference

13 August 2017

Vo AA

2

1 reference

13 August 2017

Peng A

3

1 reference

13 August 2017

Toyoda M

4

1 reference

13 August 2017

Tyan D

5

1 reference

13 August 2017

language of work or name

English

0 references

publication date

1 March 2006

1 reference

American Journal of Transplantation

13 August 2017

published in

1 reference

13 August 2017

volume

6

1 reference

13 August 2017

issue

3

1 reference

13 August 2017

page(s)

459-466

1 reference

Overview of large database analysis in renal transplantation

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.01214.X

Utility of intravenous immune globulin in kidney transplantation: efficacy, safety, and cost implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.01214.X

Antibody-mediated organ-allograft rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.01214.X

National conference to assess antibody-mediated rejection in solid organ transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.01214.X

Plasmapheresis and intravenous immune globulin provides effective rescue therapy for refractory humoral rejection and allows kidneys to be successfully transplanted into cross-match-positive recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.01214.X

Posttransplant therapy using high-dose human immunoglobulin (intravenous gammaglobulin) to control acute humoral rejection in renal and cardiac allograft recipients and potential mechanism of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.01214.X

Intravenous immune globulin treatment inhibits crossmatch positivity and allows for successful transplantation of incompatible organs in living-donor and cadaver recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.01214.X

Evaluation of intravenous immunoglobulin as an agent to lower allosensitization and improve transplantation in highly sensitized adult patients with end-stage renal disease: report of the NIH IG02 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.01214.X

Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.01214.X

A randomized and prospective study comparing treatment with high-dose intravenous immunoglobulin with monoclonal antibodies for rescue of kidney grafts with steroid-resistant rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.01214.X

Reversal of steroid- and anti-lymphocyte antibody-resistant rejection using intravenous immunoglobulin (IVIG) in renal transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.01214.X

Persistence of low levels of alloantibody after desensitization in crossmatch-positive living-donor kidney transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.01214.X

A computer match program for paired and unconventional kidney exchanges.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.01214.X

Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.01214.X

Acute vascular rejection and accommodation: divergent outcomes of the humoral response to organ transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.01214.X

Targeting adhesion molecules as a potential mechanism of action for intravenous immunoglobulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.01214.X

Economic cost of expanded criteria donors in cadaveric renal transplantation: analysis of Medicare payments

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.01214.X

Inhibition of maturation and function of dendritic cells by intravenous immunoglobulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.01214.X

10.1111/J.1600-6143.2005.01214.X

21 January 2018

Identifiers

DOI

1 reference

13 August 2017

1 reference